GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Net Margin %

CellSource Co (TSE:4880) Net Margin % : 12.26% (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CellSource Co's Net Income for the three months ended in Jan. 2024 was 円144 Mil. CellSource Co's Revenue for the three months ended in Jan. 2024 was 円1,174 Mil. Therefore, CellSource Co's net margin for the quarter that ended in Jan. 2024 was 12.26%.

The historical rank and industry rank for CellSource Co's Net Margin % or its related term are showing as below:

TSE:4880' s Net Margin % Range Over the Past 10 Years
Min: 12.39   Med: 20.47   Max: 23.82
Current: 18.4


TSE:4880's Net Margin % is ranked better than
89.2% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs TSE:4880: 18.40

CellSource Co Net Margin % Historical Data

The historical data trend for CellSource Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Net Margin % Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Net Margin %
Get a 7-Day Free Trial 12.39 14.77 22.29 23.82 20.47

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.39 17.46 21.45 22.46 12.26

Competitive Comparison of CellSource Co's Net Margin %

For the Biotechnology subindustry, CellSource Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where CellSource Co's Net Margin % falls into.



CellSource Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CellSource Co's Net Margin for the fiscal year that ended in Oct. 2023 is calculated as

Net Margin=Net Income (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=923.142/4510.544
=20.47 %

CellSource Co's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=143.901/1173.516
=12.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


CellSource Co Net Margin % Related Terms

Thank you for viewing the detailed overview of CellSource Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines